CTLA4 and neoplasm: C57BL/6 mice were inoculated with 5 x 105 tumor cells s.c. on day 0 and administered with 4 doses of anti-PD-1 or anti-CTLA-4 mAb (200 μg) every four days starting on day 4 (Fig 5A).